Anna Brinks’s research while affiliated with New York University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (17)


Call to Action: JAK Inhibitor Access and Advocacy for Alopecia Areata Patients
  • Article

April 2025

·

8 Reads

International Journal of Dermatology

Carli D. Needle

·

Anna L. Brinks

·

·

[...]

·

Kristen I. Lo Sicco


Key considerations of injectable minoxidil for alopecia

March 2025

·

30 Reads

Archives of Dermatological Research

Minoxidil has become an increasingly popular treatment option for hair loss disorders including androgenetic alopecia, cicatricial alopecia, and alopecia areata. There are various minoxidil formulations available including topical, oral, and injectable minoxidil. While injectable minoxidil may offer certain advantages, potential risks and costs should also be considered. First, we explore the enhanced bioavailability of injectable minoxidil in comparison to topical and oral formulations, as well as the variability in sulfotransferase enzyme levels and its role in the activation of minoxidil at hair follicles. Furthermore, we expand upon the potential adverse effects associated with injectable minoxidil given its widespread systemic distribution. We also highlight the importance of considering cost, access, and availability of injectable minoxidil given that injections are significantly more expensive than oral minoxidil tablets and involve the additional obstacle of frequent dermatology visits. Depending on geographic region and socioeconomic status, many patients may not live in sufficiently close proximity to a dermatologist for this level of care. Finally, we emphasize the need for ongoing research efforts to compare the efficacy, access, and tolerability of injectable minoxidil, alternative minoxidil formulations, and other alopecia medications.








Figure 1 Spatial distribution of graying for men.
Figure 2 Spatial distribution of graying for women.
Premature hair graying: a multifaceted phenomenon
  • Literature Review
  • Full-text available

December 2024

·

50 Reads

International Journal of Dermatology

Premature hair graying (PHG) is the early loss of natural hair color, influenced by genetic, biological, and environmental factors. This review discusses the significant psychological impacts of PHG and explores its underlying mechanisms, related health conditions, and available treatments. The review examines the roles of genetics, oxidative stress, and lifestyle factors such as smoking and diet in premature graying. It also considers associated medical conditions and current and emerging treatment options. This overview aims to improve understanding of PHG and its broader implications.

Download

Citations (1)


... The underlying pathophysiology is complex and multifactorial, comprising hormonal imbalance, genetic aspects, metabolic factors, and changes in hair follicle sensitivity. Each of these aspects will be analyzed in depth, after which the healthcare professional will be able to indicate appropriate treatment strategies that address the specific challenges of patients with these disorders (Desai et al., 2024). ...

Reference:

Herbal remedies and traditional treatments for hirsutism and hypertrichosis
Minoxidil-Induced Hypertrichosis: Pathophysiology, Clinical Implications and Therapeutic Strategies
  • Citing Article
  • August 2024

JAAD Reviews